SEI DBi Multi-Strategy Alternative ETF Set for Nasdaq IPO, Offering Diversified Investment Solutions
SEI DBi Multi-Strategy Alternative ETF (QALT) is preparing to debut on the Nasdaq on August 25, 2025, aiming to capture investor interest in diversified...
Scharf Global Opportunity ETF Targets Nasdaq Debut Amid Growing Investor Appetite
Scharf Global Opportunity ETF (GKAT) is scheduled for its initial public offering on the Nasdaq on August 25, 2025, marking an important moment for...
Jiaxin International Resources Invest Eyes Hong Kong Market Debut with Strategic IPO
Jiaxin International Resources Invest (3858.HK) is set to make its highly anticipated debut on the Hong Kong Stock Exchange on January 30, 2024. The...
Propanc Biopharma, Inc. (PPCB) Launches $4 Million IPO on NASDAQ Capital
Propanc Biopharma, Inc. (NASDAQ: PPCB) has officially priced its initial public offering (IPO) at $4.00 per share, raising $4 million through the sale of...
Amanta Healthcare IPO Opens September 1: Key Details and Investor Insights
Amanta Healthcare Limited, a leading pharmaceutical manufacturer, is set to launch its initial public offering (IPO) on September 1, 2025. The book-building issue consists...
